Xueqin Ruan
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Case Report: Dual resistance to dasatinib/olverembatinib in accelerated-phase cml: identification of a novel SPECC1L-inserted e8a2 BCR::ABL1 transcript and ABL1 V379I mutation.
Journal: Frontiers in oncology
Published: September 24, 2025
Enhancing multiple myeloma staging: a novel cell death risk model approach.
Journal: Clinical and experimental medicine
Published: November 12, 2023
Immune infiltration and drug specificity analysis of different subtypes based on functional status in angioimmunoblastic T-cell lymphoma.
Journal: Heliyon
Published: February 28, 2023
BP‑1‑102 exerts antitumor effects on T‑cell acute lymphoblastic leukemia cells by suppressing the JAK2/STAT3/c‑Myc signaling pathway.
Journal: Experimental and therapeutic medicine
Published: September 30, 2022
Research progress on epigenetics of small B-cell lymphoma.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: February 06, 2022
The Research Progress in Physiological and Pathological Functions of TRAF4.
Journal: Frontiers in oncology
Published: December 23, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026